Cardinal Health

437 articles with Cardinal Health

• Cardinal Health Appoints Stephen Mason To Lead Medical Segment

  7/16/2019

  Company Expects to Meet at Least the Midpoint of its Previously Announced Non-GAAP EPS Guidance for Fiscal Year '19

• Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2019 on August 8

  7/8/2019

  Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2019 on August 8 prior to the opening of trading on the New York Stock Exchange.

• Cordis Continues to Expand Interventional Cardiology Portfolio with Radial Offering

  5/14/2019

  Cordis, a Cardinal Health company, recently announced the full U.S. launch of its RADIAL 360 portfolio, offering a complete range of products to facilitate the transradial approach for interventional cardiology procedures.

• Cardinal Health Reports Third Quarter Results for Fiscal Year 2019

  5/9/2019

  Cardinal Health reported third quarter fiscal year 2019 revenues of $35.2 billion, an increase of 5 percent.

• Cardinal Health Fourth Annual Survey Finds Supply Chain Tasks Causing Stress for Clinicians and Impacting Patient Care

  5/8/2019

  Clinicians report spending more than twice the amount of time they would like to on supply chain-related tasks, and as a result have less time with patients and increased stress levels, according to the fourth annual Cardinal Health Hospital Supply Chain Survey.

• Vizient Announces Product Categories for Quarter 2 National Group Buys Program

  5/6/2019

  Philips Healthcare is the Quarter 2 Featured Supplier

• Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2019 on May 9

  4/15/2019

  The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

• Cardinal Health Partners with Perioperative Nurse to Alleviate Impact of Heat in the Operating Room

  4/8/2019

  CoolSource™ Cooling System lowers heat induced stress for surgical staff

• A New Survey from Cardinal Health Reveals Demands on Hospital Leaders' Time Take a Toll on Ability to Drive Innovation

  3/20/2019

  Three ways the hospital pharmacy can improve hospital profitability and patient outcomes

• Cardinal Health Reports Second Quarter Results for Fiscal Year 2019

  2/7/2019

  GAAP(1) operating earnings increased 26 percent to $504 million, and non-GAAP operating earnings decreased 13 percent to $637 million

• Cardinal Health Announces Brian Rice as EVP, Chief Information Officer and Customer Support Services

  1/23/2019

  Cardinal Health (NYSE: CAH) today announced that Brian Rice will join the company as executive vice president, chief information officer and customer support services. Rice's most recent role was senior vice president, chief information officer and global business services for Kellogg Company.

• Cardinal Health Foundation Supports New Initiatives at the Ohio Hospital Association to Spread Best Practices in Opioid Prescribing

  1/7/2019

  Partnership builds on Cardinal Health's Opioid Action Program and Generation Rx

• Cardinal Health Elects J. Michael Losh to its Board of Directors

  12/7/2018

  Cardinal Health today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.

• Pharmaceutical Industry Packaging Serialization Lagging as DSCSA Enforcement Deadline Looms

  10/18/2018

  Assessments by AmerisourceBergen, Cardinal Health, and McKesson Pharmaceutical Shows Nearly 80 Percent of Suppliers' Packages Do Not Meet Requirements

• Cardinal Health Welcomes Victor Crawford as CEO of Pharmaceutical Segment

  10/15/2018

  Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment.

• Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2019 on November 8

  10/15/2018

  Cardinal Health plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange.

• Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging

  10/3/2018

  Telix Pharmaceuticals (US) Inc. today announced that it has entered into a distribution agreement with Cardinal Health (NYSE:CAH).

• Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari™ (L-glutamine oral powder)

  9/19/2018

  Company Signs Fourth Major Distribution Agreement this Year

• 

  In Negotiations of 1,000 Opioid Lawsuits, Purdue Pharma Offers Free Opioid Therapy

  9/12/2018

  Purdue Pharma, best known for being the manufacturer of opioid drug OxyContin, is offering free doses of a treatment for opioid abuse as part of negotiations in more than 1,000 lawsuits.

• Cardinal Health Board of Directors Approves Quarterly Dividend of $0.4763 Per Share

  8/8/2018

  The Cardinal Health (NYSE: CAH) board of directors approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to shareholders of record at the close of business on October 1, 2018.